Results 141 to 150 of about 25,610 (245)

Soluble Urokinase-type Plasminogen Activator Receptor Predicts All-cause 5-Year Mortality in Ischemic Stroke and TIA [PDF]

, 2017
Juha Onatsu, Mikko Taina, Pirjo Mustonen, Marja Hedman, Antti Muuronen, Otso Arponen, Miika Korhonen, Pekka Jäkälä, Ritva Vanninen, Kari Pulkki   +9 more
openalex   +1 more source

Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.

J Am Soc Nephrol, 2020
Azam TU, Shadid HR, Blakely P, O'Hayer P, Berlin H, Pan M, Zhao P, Zhao L, Pennathur S, Pop-Busui R, Altintas I, Tingleff J, Stauning MA, Andersen O, Adami ME, Solomonidi N, Tsilika M, Tober-Lau P, Arnaoutoglou E, Keitel V, Tacke F, Chalkias A, Loosen SH, Giamarellos-Bourboulis EJ, Eugen-Olsen J, Reiser J, Hayek SS, International Study of Inflammation in COVID-19.   +27 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor Levels in Tuberculosis Patients at High Risk for Multidrug Resistance [PDF]

, 2012
Tri Yudani Mardining Raras, Triwahju Astuti, Iin Noor Chozin   +2 more
openalex   +1 more source

Inactivation of urokinase-type plasminogen activator receptor induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice closely mimicking human systemic sclerosis

, 2014
Mirko Manetti, Irene Rosa, Anna Franca Milia, Dalila Conte, Martina Ruffo, Peter Carmeliet, Marco Matucci‐Cerinic, Lidia Ibba‐Manneschi   +7 more
openalex   +1 more source

Identification of plasminogen activator urokinase receptor-related non-coding RNA and immune prognostic signature for non-small cell lung cancer. [PDF]

Clinics (Sao Paulo)
Cheng Y, Bao S, Zhang H, Zhang Y, Li X, Li H, Jia X, Sun Q, Song Z.   +8 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Predictive Biomarker for Renal Failure Stratification and Urinary Tract Infections in Hemodialysis Patients

Karbala journal of Medicine Manager, Ahmed Hasen Kaser Alkarewy, Ali Jalil Ali Alyassery, Ahmed.hassen s.uokerbala.edu.iq   +3 more
openalex   +2 more sources

Development of Novel Therapeutics Targeting the Urokinase Plasminogen Activator Receptor (uPAR) and Their Translation Toward the Clinic

, 2011
Andrew P. Mazar, Richard W. Ahn, Thomas V. O’Halloran   +2 more
openalex   +2 more sources

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. [PDF]

, 1997
David Waltz, Lisa Natkin, Ross M. Fujita, Ying Wei, Harold A. Chapman   +4 more
openalex   +1 more source

RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth

, 2006
Shakuntala Kondraganti, Christopher S. Gondi, Ian E. McCutcheon, Dzung Dinh, Meena Gujrati, Jasti Rao, William C. Olivero   +6 more
openalex   +2 more sources

ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts [PDF]

, 1997
Hans de Witte, Helle Pappot, Nils Brünner, J Grøndahl-Hansen, Gunilla Høyer‐Hansen, Niels Behrendt, Birgit Guldhammer-Skov, Fred C.G.J. Sweep, Theo Benraad, Keld Danø   +9 more
openalex   +1 more source